Ayurvedic management of vata rakta(Gout) by Siravedhana and Mustadi Yapana Basti
- Conditions
- Gout, unspecified. Ayurveda Condition: VATARAKTAM,
- Registration Number
- CTRI/2025/06/088989
- Lead Sponsor
- Parul Institute of Ayurveda
- Brief Summary
**Introduction**
*Vatarakta* (Gout) is a complex form of inflammatory arthritis characterized by recurrent episodes of intense pain, swelling, and redness in the affected joints, most commonly the big toe. This condition arises from the accumulation of monosodium urate crystals in the synovial fluid, a consequence of hyperuricemia. In Ayurveda, we can co-relate to *Vatarakta*, a vyadhi caused by the imbalance of *Vata* and *Rakta.* When aggravated *Vata* is blocked by vitiated *Rakta*, leading to further aggravation of *Vata.* *Vatarakta* has two stages: *Uttana* (mild) which primarily affects the *twak*, *rakta,* and *mamsa* while *gambhira vatarakta* affects deeper tissues such as asthi, sandhi and snayu, often described as more severe and persistent. It is considered a serious disease, with severe joint pain being the most prominent symptom and affects the hands and feets later on spreading to other joints. This pain can significantly disrupt daily life, making it difficult for individuals to use the affected joints. Ayurveda offers treatment options for *Vatarakta*, including *Shodhana* (purification therapies), *Shamana* (palliative medicines), and *Rasayana* (rejuvenation therapies). Given this context, there is a need for research to evaluate the efficacy of *Raktamokshana* along with *modified bala guduchyadi yapana basti* and *mustadi yapana basti* in managing *Vatarakta.*
**Need of the study**:
Ayurvedic Management of Vatarakta (Gout) with Siravedhana and Yapana Basti: A Holistic Approach Gout, a metabolic disorder characterized by elevated uric acid levels and painful joint inflammation, is increasingly prevalent worldwide, with a global prevalence of 1–4% and incidence of 0.1–0.3%. It commonly coexists with conditions such as hypertension, cardiovascular disease, obesity, and diabetes. Men are disproportionately affected compared to women (3:1 to 10:1). Despite its growing burden, modern medicine lacks a definitive long-term management protocol, especially for recurrent familial cases.
In Ayurveda, gout correlates with Vatarakta, a condition involving the vitiation of Vata and Rakta. Treatment focuses on both Shodhana (purification) and Shamana (palliation) therapies. Among the Shodhana therapies, Siravedhana (therapeutic bloodletting) plays a crucial role. It helps in directly removing Dushta Rakta (vitiated blood) along with Ama (toxins) and excess Pitta, thereby detoxifying the circulatory system. This elimination process helps to unblock the Rakta Vaha Srotas (blood channels), reduce systemic inflammation, and restore Agni (digestive fire), reducing further toxin accumulation.
Another key treatment is Yapana Basti (medicated enema), which is both Rasayana (rejuvenative) and Vata-pacifying. Unlike aggressive purgative Bastis, Yapana Basti nourishes and strengthens the body while gently balancing Vata. It plays a significant role in mitigating pain, stiffness, and other Vata-related symptoms of Vatarakta. It also supports the regeneration and nourishment of Dhatus (tissues), particularly Rakta Dhatu, promoting long-term recovery of affected joints and muscles.
Modified Mustadi Yapana Basti and Bala Guduchyadi Yapana Basti are specific formulations used in Vatarakta. Musta (Cyperus rotundus) is known for its anti-inflammatory and Ama-pachana actions, while Guduchi (Tinospora cordifolia), especially when processed with milk (Ksheera), offers immunomodulatory, anti-inflammatory, and tissue-rejuvenating benefits. Bala (Sida cordifolia) adds a strengthening effect, further supporting tissue repair and vitality.
This combined approach—Siravedhana followed by specific Yapana Bastis—offers a comprehensive Ayurvedic protocol to address the root pathology of Vatarakta. These therapies work synergistically to detoxify, nourish, and restore balance, ultimately improving joint function, relieving pain, enhancing strength, and boosting Ojas (vital energy).
Despite promising clinical outcomes, there is a lack of systematic, evidence-based studies evaluating the combined efficacy of Siravedhana and these Basti formulations in Vatarakta. The current study aims to fill this gap by assessing therapeutic effects through standardized clinical tools such as Visual Analogue Scale (VAS), Range of Motion (ROM), and symptom scoring.
A well-designed, evidence-backed Ayurvedic protocol for Vatarakta can serve as an effective alternative or adjunct to conventional treatments, offering safe and holistic care for patients suffering from this chronic and debilitating disease.
Review of literature:
Charaka Samhita
Charaka Samhita, Chikitsa sthana, 29th chapter
Sushruta Samhita, 5th chapter of chikitsa sthana
Bhaisajya ratnavali 5th chapter
Aim:
To study the Shodhana effect of Siravedhana followed by Modified bala guduchyadi yapana basti and mustadi yapana basti in the management of vatarakta w.s.r to Gout
Objectives:
1. To study the efficacy of Siravedhana followed by Bala guduchyadi yapana basti in the management of vata rakta
2. To study the efficacy of Siravedhana followed by Modified mustadi yapana basti in the management of vata rakta
3. To compare the efficacy of Siravedhana followed bymustadi yapan basti and bala guduchyadi yapana basti in the management of vata rakta.
4. To observe the shodhana effect of Siravedhana.
5. To observe and evaluate the rehabilitation efficacy of yapana basti in vatarakta patients.
Research Question:
Is *Siravedhana* followed by Modified *Bala Guduchyadi yapana basti* and *Mustadi yapan basti* effective in management of *vatarakta*?
Hypothesis:
Null Hypothesis(H0): Neither Siravedhana followed by Modified bala guduchyadi yapana basti nor Siravedhana followed by mustadi yapana basti is effective in management of vatarakta.
Alternate hypothesis:
(H1) Siravedhana followed by modified bala guduchyadi yapana basti is effective in the management of vatarakta.
(H2) Siravedhana followed by mustadi yapana basti is effective in management of vatarakta.
(H3) Siravedhana followed by modified mustadi yapana basti and bala guduchyadi yapana basti are effective in the management of vatarakta.
**Materials**
**1. Source of data:**
**A). Literary****source:-** All the available classical, modern literature and contemporary text including the journals and online websites regarding the vata rakta basti karma, siravedhana and gout will be reviewed and documented for the study.
**B). Pharmaceutical source:-** All raw drugs will be purchased from registered shops/store.Preparation of drug will be done in GMP certified pharmacy.
**C). Clinical source:****-**Patients diagnosed with vatarakta will be selected from OPD and IPD of Parul Ayurved Hospital, Limda, Vadodara, Parul Sevashram Hospital, Vadodara**.**
**Methodology:**
**Sample size** - 20
**Study design** : Randomized Comparative clinical study pre and post assessment.
**Study duration:** 18 months
**Follow up** : 3 Follow ups, one on zero day, second follow up on 4th day and 3rd follow up on 20th day.
**Duration of treatment**: 12 Days
**Selection Criteria:** 20 Patient will be selected from OPD and IPD of Parul Ayurveda Hospital, Parul University and various Health Checkup Camps
**Screening investigation**
Hb**,**ESR**,**RBS**,**Serum Uric acid**,**CBC**,**CRP
**Inclusion Criteria: -**Subjects presenting with classical clinical features of Vatarakta.**,** of either gender between age group of 18-70 year, fit for Niruha and Anuvasna basti karma with serum Uric Acid level above 6 mg /dl in female and above 7 mg/dl in male.
**Exclusion criteria**: Subjects with chronic autoimmune disease of joints & subsequent joint deformity, with uncontrolled metabolic systemic disorder like HTN and DM, pregnant and lactating women, those contraindicated for Niruha and Anuvasana Basti and having Alpa bala.
**Diagnostic Criteria**
On the basis of classical clinical sign and symptoms we diagnosed the case as Vatarakta
**Assessment criteria**
**1.** **Subjective Criteria-***Sandhishula, Daha, Sandhisotha, Sparshaasahatva, Twak lohita* and Visual analog scale
| | | |
| --- | --- | --- |
|Sln.
Sandhishoola
Grade
|1
No Pain
0
|2
Mild Pain
1
|3
Moderate
2
|4
Severe Pain
3
|Sln.
Sparshshashatva
Grade
|1
No Tenderness
0
|2
Pt. Say Tenderness
1
|3
Winching Of Face On Touch
2
|4
Does Not Allow To Touch
3
|Sln
Colour Of Joint
Grade
|1
Normal Skin Colour
0
|2
Red Colour
1
|3
Brown Colour
2
|4
Black Colour
3
|Sln
Swelling
Grade
|1
No Swelling
0
|2
Mild Swelling 0-3mm
1
|3
Moderate Swelling / Shiny 3-6mm
2
|4
Severe Swelling / Redness 6mm
3
**2.** **Objective criteria**
| | | | | |
| --- | --- | --- | --- | --- |
|S. No
Serum uric acid
LAB Value mg/dl female
LAB value mg/dl male
Grade
|1
Normal
0-6
0-7
0
|2
Mild
6.1-7
7-8
1
|3
Moderate
7.1-8
8
2
|4
Severe
8 and Above
8 and above
3
ROM (Range of movement)
| | |
| --- | --- |
|**Upper Limb**
**Lower Limb**
|Shoulder – Flexion, Extension, Abduction, Adduction, Medial rotation and lateral Rotation
Hip -Flexion, Extension, Abduction, Adduction, Medical Rotation and Lateral Rotation
|Elbow - Flexion and Extension
Knee - Flexion and Extension
|Radioulnar- Supination, Pronation
Ankle - Plantar Flexion and Dorsal Flexion
|Wrist - Extension, Radial Deviation, Ulnar Deviation
Sub Talar joint - Inversion, Eversion
**Intervention:-** 20 Patients of vatarakta fulfilling the inclusion criteria will be randomly selected and assigned into following 2 groups:-
| | | |
| --- | --- | --- |
|Group
Number of patients
Treatment
|Group A
10 Patients
Siravedhana followed by Modified mustadi yapana basti
|Group B
10 Patients
Siravedhana followed by modified Bala guduchyadi yapana basti
**Treatment protocol**
| | | |
| --- | --- | --- |
|**DAY**
GROUP A
GROUP B
|**For 1-2 days**
After achieving Nirama lakshanas Sadyo snehapana with murchita go-ghrita (acc. to agnibala)
After achieving Nirama lakshanas Sadyo snehapana with murchita go-ghrita (acc. to agnibala)
|**3rd day**
*Sarvanga abhyanga* with pinda taila followed by *nadi swedana*
*Tila yavagu pana* 50 -150 ml approx) and *Siravedhana* – as per Bala of patient
|**4th day** (after achieving nirama lakshanas)
|**5th day- 12th day**
Modified mustadi yapana basti
Modified bala guduchyadi yapana basti
**Basti karma schedule**
| | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
|Day1
Day2
Day3
Day 4
Day 5
Day 6
Day 7
Day 8
|Y.B
Y.B
Y.B
Y.B
Y.B
Y.B
Y.B
Y.B
**Modified Mustadi Yapana Basti**
| | |
| --- | --- |
|Saindhava Lavana
12gm
|Sneha
Murchita Go-Ghrita = 50ml
|Kalka
Madanphala, Shatapushpa, Kutaja, Priyangu=20gm
|Kwatha
Mustadi Ksheer Paka = 350ml
(Musta, bala, Aragvadha, rasna, manjistha, Punarnava, bibhitaki, bruhati)
|Total = 512ml
**Modified Bala guduchyadi yapana basti**
| | |
| --- | --- |
|Madhu
80ml
|Saindhava lavana
12gm
|Sneha
Murchita Go-Ghrita 50ml
|Kalka
Bala, Eranda, Manjistha, Nimba, Punarnavadi= 20gm
|Kwatha
Guduchyadi ksheer paka = 350ml
(Guduchi, bala, Dashmool, Rasna
|Total 512ml
**SOPs**
**Siravedhana Karma**
| | | |
| --- | --- | --- |
|**Purvakarma**
**Pradhana karma**
**Paschat karma**
|• Written consent for the procedure will be taken
\* Sadyo Snehapana will be given to the patient for 1- 2 days
On the 3rd day and 4th day, Sarvanga abhyanga with pinda taila followed by nadi swedana and pitta prakopaka ahara is advised to the patient.
\* Tila Yavagu pana(Utkleshanarth Yavagu) will be given on the day of Siravedhana before main procedure.
\* Vital checking prior to procedure.
• Patient made to sit or lie down comfortably.
\* Patient eye will be covered with eye pad/cloth.
• Apply a tourniquet tightly above the site of punctured; the area is cleaned with spirit and cotton.
\* The nearest vein is select according to effected side to be punctured.
\* The needle is to be inserted into the desired vein.
\* The blood is collected in beaker.
• When blood flow reduces, remove the tourniquet.
\* Clean the site and apply bandage over the punctured area.
• The patient is advised to rest for 15-20 minutes.
**Basti**
| | | |
| --- | --- | --- |
|**Poorvakarma**
**Pradhanakarma**
**Paschatkarma**
|Counselling of the Patient, *Basti* Preparation.
**Bgb –** Selection of The Patient, Counselling of The Patient, *Basti* Preparation.
*Modified Mustadi Yapana Basti* Administration at *Na ati*-*Kshudharta State.*
**Bgb –** *Modified Bala Guduchyadi Yapana Basti* Administration at *Na ati-Kshudharta* State
Rest, *Snana, Laghu Bhojana* Advised, *Basti Pratyagamana Kala* and Number of *Vega* Will Be Noted.
**Bgb –** Rest, *Snana, Laghu Bhojana* Advised*, Basti Pratyagamana Kala* and Number of *Vega* Will Be Noted.
**STASTICAL ANALYSIS:**Collected data and observation will be analyzed critically and scientifically by employing statistical tests.
**ETHICAL CLEARANCE:** Ethical clearance will be obtained from Institutional Ethics Committee before starting the study and this study will be registered in the Clinical Trial Registry of India.
**DECLARATION** : Study will be completed in stipulated time.
**CRITERIA OF WITHDRAWAL**
Cases included in study will be withdrawal from the study if they develop any complication and such cases will be referred to concerned consultant for further management.
**REPORTING OF ADVERSE DRUG REACTION TO PHARMACOVIGILANCE DEPARTMENT -**
If any Adverse Drug reaction occurred during the study, it will be duly noted, and informed to pharmacovigilance cell of Parul Ayurveda Hospital, and treated accordingly or referred to Parul Sevasharam Hospital.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 20
- Subjects presenting with classical clinical features of Vatarakta.
- Subjects of either gender between age group of 18-70 yr.
- Subjects fit for Niruha and Anuvasna basti karma.
- Uric Acid level ABove 6 mg /dl in female.
- Uric acid level ABove 7 mg/dl in male.
- Subjects with chronic autoimmune disease of joints & with joint deformity due to it 2.
- Subjects with uncontrolled metabolic systemic disorder like HTN and DM 3.
- Pregnant and lactating women.
- Subjects contraindicated for Niruha and Anuvasana Basti.
- Subjects with Alpa bala.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in symptoms of Vatarakta 4th day of treatment- first follow up and assesment of parameters | 20th day of treatment- second follow up and assesment of parameters
- Secondary Outcome Measures
Name Time Method Reduction in uric acid levels 4th day of treatment- first follow up & assesment of parameters
Trial Locations
- Locations (1)
Parul Ayurved Hospital
🇮🇳Vadodara, GUJARAT, India
Parul Ayurved Hospital🇮🇳Vadodara, GUJARAT, IndiaDr VikasPrincipal investigator07533088547vikaspandit0007@gmail.com